Platinum-resistant or Refractory Ovarian Cancer
1 clinical trials · Condition
◉ Watch Platinum-resistant or Refractory Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer (NCT02591095) | Centre Francois Baclesse | 2016-01-01 |
Track Platinum-resistant or Refractory Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.